CORRECTS: BioNTech and Pfizer ask European regulator for expedited approval of their COVID-19 vaccine
BERLIN (AP) — CORRECTS: BioNTech and Pfizer ask European regulator for expedited approval of their COVID-19 vaccine.
WASHINGTON (AP) — President Donald Trump misstated the facts Thursday when he asserted that the Food and Drug Administration had just approved a decades-old malaria drug to treat patients infected...
TRENTON, N.J. (AP) — U.S. regulators want to know why Novartis didn't disclose a problem with testing data until after the Swiss drugmaker's $2.1 million gene therapy was approved.
TRENTON, N.J. (AP) — In a story Nov. 8 about a new drug approval, The Associated Press misspelled the drug's name. It is Prevymis, not Prevymix.
A corrected version of the story is below:
FDA OKs drug to block infection after marrow transplant
U.S. regulators approve new drug to prevent life-threatening infections in adults after a bone marrow transplant
WASHINGTON (AP) — A unanimous Supreme Court is speeding up the time for generic biotech drugs to become available to the public in a ruling that means a loss of billions in sales to the makers of original versions.
The justices ruled Monday in favor of generic drug maker Sandoz in its dispute with rival Amgen over a near-copy of Amgen's cancer drug Neupogen.
WASHINGTON (AP) — A conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry is President Donald Trump's pick to lead the Food and Drug Administration.
WASHINGTON (AP) — The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
WASHINGTON (AP) — Republicans and Democrats put finishing touches Tuesday on a $6.3 billion medical research bill as GOP leaders prepared to try pushing the measure through the lame-duck Congress by next week. The White House said it backs the measure, all but ensuring its approval.